|
ZNF695 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.567600E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.495600E-01 |
| Normal-vs-Stage2 |
1.941970E-01 |
| Normal-vs-Stage3 |
1.610370E-01 |
| Normal-vs-Stage4 |
2.977800E-01 |
| Stage1-vs-Stage2 |
9.909000E-01 |
| Stage1-vs-Stage3 |
9.564800E-01 |
| Stage1-vs-Stage4 |
5.927600E-01 |
| Stage2-vs-Stage3 |
9.622200E-01 |
| Stage2-vs-Stage4 |
6.583400E-01 |
| Stage3-vs-Stage4 |
5.980000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.331360E-01 |
| Normal-vs-AfricanAmerican |
2.182800E-01 |
| Normal-vs-Asian |
2.017800E-01 |
| Caucasian-vs-AfricanAmerican |
9.313600E-01 |
| Caucasian-vs-Asian |
7.851400E-01 |
| AfricanAmerican-vs-Asian |
8.066400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.487800E-01 |
| Normal-vs-Female |
1.369000E-01 |
| Male-vs-Female |
4.199200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.588300E-02 |
| Normal-vs-Age(41-60Yrs) |
4.431200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.063800E-02 |
| Normal-vs-Age(81-100Yrs) |
7.288400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.539000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.427000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.301000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.795700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.934600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.392800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.286800E-01 |
| Classical-VS-Follicular |
3.415800E-02 |
| Classical-VS-Other |
6.835400E-01 |
| Classical-VS-Normal |
9.820200E-02 |
| Tall-VS-Follicular |
2.762400E-01 |
| Tall-VS-Other |
5.582600E-01 |
| Tall-VS-Normal |
1.919780E-01 |
| Follicular-VS-Other |
2.561400E-01 |
| Follicular-VS-Normal |
5.336200E-01 |
| Other-VS-Normal |
3.808800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.881970E-01 |
| Normal-vs-N1 |
1.608390E-01 |
| N0-vs-N1 |
7.647800E-01 |
|
|
